Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA panel fixes the...

NPPA panel fixes the retail price of uncoated sustained-release tablets containing Medroxyprogesterone Acetate, details

Dr. Divya ColinWritten by Dr. Divya Colin Published On 2022-03-29T18:27:14+05:30  |  Updated On 29 March 2022 6:27 PM IST
NPPA panel fixes the retail price of uncoated sustained-release tablets containing Medroxyprogesterone Acetate, details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of uncoated sustained release tablet containing Medroxyprogesterone Acetate IP 30 mg, manufactured by Synokem Pharmaceuticals and marketed by Serum Institute of India Limited.

In addition to this, the NPPA has fixed the retail price of uncoated sustained release tablet containing Medroxyprogesterone Acetate IP 30 mg manufactured by Synokem Pharmaceuticals and marketed by Torrent Pharmaceuticals.

The retail price of each uncoated sustained-release tablet containing Medroxyprogesterone Acetate IP 30 mg has been set at Rs 14.04 per tablet excluding GST.

Medroxyprogesterone is a progestin (a form of progesterone), a female hormone, that helps regulate ovulation and menstrual periods. Ovulation is the process of the release of an egg from an ovary.

Medroxyprogesterone is used to treat conditions such as irregular or absent menstrual periods, or abnormal uterine bleeding. It is also used to decrease the risk of endometrial hyperplasia (a condition that may lead to uterine cancer) while taking estrogens.

Medroxyprogesterone is also used as part of combination hormone replacement therapy with estrogens to reduce menopause symptoms (such as hot flashes). Medroxyprogesterone is added to estrogen replacement therapy to reduce the risk of cancer of the uterus.

This drug is not recommended during pregnancy as it causes birth defects. The drug is also not recommended during breastfeeding as it passes through breast milk.

Medroxyprogesterone acetate inhibits gonadotropin production, reduces nuclear estrogen receptors and DNA synthesis in epithelial cells of the endometrium, and induces p53 dependant apoptosis in cancer cell lines. These oral tablets have a half-life of 40-60 hours.

Medroxyprogesterone acetate inhibits the production of gonadotropin, thus preventing follicular maturation and ovulation, which is responsible for its ability to prevent pregnancy. This action also thins the endometrium.

This recommendation came during the 40th meeting of the Multidisciplinary Committee of Experts, held on March 14, 2022, under the convenorship of Shri Manmohan Sachdeva, Advisor(cost), through video-conferencing.

After detailed deliberation, the Committee recommended the retail price of each uncoated sustained release tablet containing Medroxyprogesterone Acetate IP 30 mg, for Synokem Pharmaceuticals Limited (manufacturer) and Serum Institute of India Limited ( marketer) at Rs 14.04 per tablet excluding GST as detailed below.

Computation of Retail Price per Tablet

Source/Tablet

Amount

Derived retail price of Medroxyprogesterone acetate sustained-release tablets 30mg

Note 1

Rs.14.04 per tablet excluding GST

Company Claimed Price excluded GST(per tablet)

Rs.16.52

Recommended price excluding GST(per tablet)

Rs.14.04

Note 1

Derived retail price as per recommended of pronabsen committee:

P(s)=P*[1+a{(s-s*)/s*}]

Where :P(s)=Price ceiling of strengths

P*=pricing ceiling for reference strengths

S=strength in terms of API content

s*=reference strength

a=0.8for tablets/capsule and 0.7 for injections

Similarly, the Committee deliberated upon the matter in detail and recommended the retail price of each uncoated sustained release tablet contains Medroxyprogesterone Acetate IP 30 mg for Synokem Pharmaceuticals (manufacturer) and Torrent Pharmaceuticals (marketer) at Rs. 14.04 per tablet excluding GST as detailed below:

Computation of Retail Price per Tablet

Source/ Method

/- mount (Rs.)

Derived retail price of Medroxyprogesterone Acetate Sustained Release Tablets 30 mg

Note 1

Rs. 1 4.04 per tablet

excluding GST

Company Claimed Price excluding GST (per tablet)

Rs. 2 0.50

Recommended tablet)

price

excluding

GST

( per tablet)

Rs. 1 4. 04

Note 1. Derived retail price as per recommendation of pronabsen commit tee : P(s) = P*.[1+a.{(s-s*)/ s*}]

Where : P(s) =Price ceiling of the strengths

P* = price ceiling for reference strength s* s = strength in terms of API content

s* = reference strength

a= 0.8 for tablet / capsule and 0. 7 for injectibles

Also Read: NPPA panel fixes the retail price of spray containing Diclofenac, Methyl Salicylate, Menthol, Details
Medroxyprogesterone AcetatenppaSynokem PharmaceuticalsSerum Institute of Indiatorrent
Dr. Divya Colin
Dr. Divya Colin

    Doctor of Pharmacy

    Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 28/May/2025

    Health Bulletin 28/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok